Edition:
United Kingdom

Nichi-Iko Pharmaceutical Co Ltd (4541.T)

4541.T on Tokyo Stock Exchange

1,692JPY
2:28am GMT
Change (% chg)

¥-13 (-0.76%)
Prev Close
¥1,705
Open
¥1,703
Day's High
¥1,707
Day's Low
¥1,690
Volume
150,800
Avg. Vol
392,825
52-wk High
¥1,895
52-wk Low
¥1,540

Latest Key Developments (Source: Significant Developments)

Nichi-Iko Pharmaceutical fully buys Sagent Pharmaceuticals, Inc. via takeover bid
Monday, 29 Aug 2016 

Nichi-Iko Pharmaceutical Co Ltd <4541.T>:Says it completed full acquisition of Sagent Pharmaceuticals, Inc. via takeover bid, effective Aug. 29(the U.S. time).  Full Article

Shepard Vision commences all-cash tender offer of $21.75 net per share to buy shares of Sagent
Monday, 1 Aug 2016 

Shepard Vision Inc:Commences all-cash tender offer of $21.75 net per share to acquire all outstanding shares of Sagent Pharmaceuticals, Inc.  Full Article

Sagent Pharma will be required to pay Nichi-Iko Pharma $24.3 mln upon termination of deal
Monday, 11 Jul 2016 

Sagent Pharmaceuticals Inc :Upon termination of deal, under specified circumstances, co will be required to pay Nichi-Iko Pharma termination fee of $24.3 million.  Full Article

Japan's Nichi-Iko to buy Sagent Pharmaceuticals for $21.75 per share in cash
Monday, 11 Jul 2016 

Sagent Pharmaceuticals Inc : Nichi-Iko pharmaceutical Co, Ltd to acquire Sagent Pharmaceuticals for $21.75 per share in all cash transaction . Deal for approximately $736 million . Nichi-Iko intends to finance acquisition through bank loans and available cash .Transaction unanimously approved by Nichi-Iko and Sagent boards of directors.  Full Article

Nichi-Iko Pharmaceutical completes share repurchase
Tuesday, 5 Apr 2016 

Nichi-Iko Pharmaceutical Co Ltd:Completes repurchase of 2,846,800 shares of its common stock, at the price of 7,000,281,200 yen in total, on April 5.  Full Article

Nichi-Iko Pharmaceutical to repurchase shares
Monday, 4 Apr 2016 

Nichi-Iko Pharmaceutical Co Ltd:To repurchase up to 2,846,800 shares, representing a 4.76 pct stake, on April 5.Says share repurchase up to 7,000,281,200 yen in total.  Full Article

Nichi-Iko Pharmaceutical raises consolidated full-year net profit outlook for FY 2016
Tuesday, 9 Feb 2016 

Nichi-Iko Pharmaceutical Co Ltd:Says the company reaffirmed the consolidated full-year outlook for revenue at 140,000 mln yen for the fiscal year ending March 31, 2016.Confirms the operating profit forecast at 12,500 mln yen.Confirms the ordinary profit forecast at 12,100 mln yen.Net profit forecast increased to 11,000 mln yen from 8,000 mln yen.Earnings per share increased to 183.92 yen from 133.77 yen.Says gain from sale of securities as main reason for the forecast.  Full Article

BRIEF- Nichi-Iko Pharmaceutical says merger with wholly owned unit

Oct 2Nichi-Iko Pharmaceutical Co Ltd * Says it merged with a wholly owned unit, on Oct. 1 Source text in Japanese:https://goo.gl/Zi3Hxh Further company coverage: (Beijing Headline News)